The theory of “glucocorticoid resistance” in MDD was proposed in the late 1990s, suggesting that glucocorticoid receptors in individuals with MDD demonstrate diminished sensitivity to cortisol and are functionally compromised [80]. This evidence concerns the gene NR3C1 and major depressive disorder.